Abvc Biopharma, Inc.: Form 8-K, filed Apr 15, 2025
Filed with the SEC on Apr 15, 2025 and accepted by EDGAR at Apr 15, 2025, 16:30 ET.
Items reported
- Item 2.02 Results of operations
- Item 4.02 Non-reliance on financial statements
- Item 7.01 Regulation FD disclosure
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001213900-25-032135. Last ingested by Listed: Nov 2, 2026, 09:52 ET. Listed shows no prices and gives no investment advice.